 |
 |
|
|
|
sarpogrelate |
 |
(¡¾)-1-{2-[2-(3-Methoxyphenyl)ethyl]phenoxy}-3-(dimethylamino)-2-propyl Hydrogene Succinate |
 |
125926-17-2 |
 |
is a serotonin 2A receptor antagonist and is clinically used for the cutaneous ulcer |
 |
powder |
Industrial field |
pharmaceutical |
|
|
 |
|
|
|
 |
There are no existing companies to distribute selected chemical product |
|
 |
|
|
|